Arbutus Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arbutus Biopharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-0.10 | $-0.09 | -11.1 % |
Jun 2024 | 2024-08-01 | $-0.11 | $-0.10 | -10.0 % |
Mar 2024 | 2024-05-02 | $-0.10 | $-0.11 | 9.09 % |
Dec 2023 | 2024-02-29 | $-0.12 | $-0.12 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $1.34M | $1.86M | -28.0 % |
Jun 2024 | 2024-08-01 | $1.73M | $1.75M | -1.37 % |
Mar 2024 | 2024-05-02 | $1.53M | $2.15M | -28.7 % |
Dec 2023 | 2024-02-29 | $2.15M | $4.79M | -55.2 % |
Arbutus Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3.
Arbutus Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was $-0.10, which missed the estimate of $-0.09.
Arbutus Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.